raloxifene hydrochloride has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Menniti, FS; Ramirez, AD | 1 |
| Bourque, M; Di Paolo, T; Morissette, M | 1 |
2 other study(ies) available for raloxifene hydrochloride and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2003 |
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Estradiol; Male; Mice, Inbred C57BL; Neuroprotective Agents; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction | 2014 |